Gordon R. B. Skinner

Corporate Officer/Principal at Vaccine Research International Plc

81 year

Commercial Services

Health Technology

Consumer Services

Profile

Dr. Gordon R.
Skinner, MD, is a Director & Research Director at Grupo International, Inc. and a Managing Director at Vaccine Research International Plc.
He is on the Board of Directors at Grupo International, Inc. and Intracell Vaccines Ltd.
Dr. Skinner was previously employed as a Board Member & Research Director by HIV-VAC, Inc. He received his undergraduate degree from the University of Glasgow, a doctorate degree from the University of Birmingham, and a doctorate degree from the University of Birmingham.

Gordon R. B. Skinner active positions

Companies	Position	Start
Vaccine Research International Plc Vaccine Research International Plc Miscellaneous Commercial ServicesCommercial Services Vaccine Research International Plc is a British company that focuses on conducting clinical trials to evaluate the effectiveness of vaccine SA75 in preventing staphylococcal infections in hospital patients and the wider community.	Corporate Officer/Principal	2010-04-08

All active positions of Gordon R. B. Skinner

Former positions of Gordon R. B. Skinner

Companies	Position	End
HIV-VAC, Inc. HIV-VAC, Inc. Miscellaneous Commercial ServicesCommercial Services HIV-VAC, Inc. develops and markets proposed vaccine designed to combat HIV/AIDS. This proposed vaccine, which is called NFU.Ac.HIV, was developed by Dr. Gordon Skinner, director of research, through the University of Birmingham, in the U.K. The proposed vaccine was licensed to Intracell Vaccines Limited from the University of Birmingham. The company was founded in 1997 and is headquartered in Ontario, CA.	Chief Tech/Sci/R&D Officer	2010-10-27
GRUPO INTERNATIONAL INC.	Chief Tech/Sci/R&D Officer	-
Intracell Vaccines Ltd. Intracell Vaccines Ltd. Medical SpecialtiesHealth Technology Intracell Vaccines Ltd. develops vaccines. The company is headquartered in Gaithersburg, MD.	Director/Board Member	-

See the detail of Gordon R. B. Skinner's experience

Training of Gordon R. B. Skinner

University of Glasgow	Undergraduate Degree
University of Birmingham	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Gordon R. B. Skinner's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
GRUPO INTERNATIONAL INC.	Health Technology

Private companies	3
HIV-VAC, Inc. HIV-VAC, Inc. Miscellaneous Commercial ServicesCommercial Services HIV-VAC, Inc. develops and markets proposed vaccine designed to combat HIV/AIDS. This proposed vaccine, which is called NFU.Ac.HIV, was developed by Dr. Gordon Skinner, director of research, through the University of Birmingham, in the U.K. The proposed vaccine was licensed to Intracell Vaccines Limited from the University of Birmingham. The company was founded in 1997 and is headquartered in Ontario, CA.	Commercial Services
Intracell Vaccines Ltd. Intracell Vaccines Ltd. Medical SpecialtiesHealth Technology Intracell Vaccines Ltd. develops vaccines. The company is headquartered in Gaithersburg, MD.	Health Technology
Vaccine Research International Plc Vaccine Research International Plc Miscellaneous Commercial ServicesCommercial Services Vaccine Research International Plc is a British company that focuses on conducting clinical trials to evaluate the effectiveness of vaccine SA75 in preventing staphylococcal infections in hospital patients and the wider community.	Commercial Services

See company connections